Conference abstract · 2017
Conference abstractPublished 6 Oct 2015
Novel biodegradable polymeric nanoparticle development using quality by design
Howard University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The relatively new concept of quality by design (QbD) in pharmaceutical dosage form design and development, already incorporated into automakersâÂ?Â? production principles, involves designing and developing drug formulations and manufacturing processes which ensure predefined drug product specifications. An important part of QbD is to understand how process and formulation variables affect product characteristics and subsequent optimization of these variables vis-Ã? -vis the final specifications. Statistical design of experiments (DoE) is a well-established method for identifying important parameters in a pharmaceutical dosage form design and optimizing the parameters with respect to certain specifications; DoE is a valuable tool to establish in mathematical form the relationships between critical process parameters (CPPs) together with the critical material attributes (CMAs) and critical quality attributes (CQAs). Further, DoE can help identify optimal conditionsquickly as well as facilitate robustness testing. Approaches to DoE (to examine all the variables simultaneously) are factorial and mixture experimental designs. When the responses or nanoparticle properties are known to depend on the proportions of the ingredients, DoE involving mixture methodologyis preferred. When a formulation is a mixture of various components (proportion of the constituents: macomonomer, crosslinker, stabilizer and initiator system) as studied in this work and the levels of the components are constrained, D-optimal mixture design is more useful than a factorial design because it accounts for the dependence of response on proportionality of constituents. Our data on two nanoparticle systems (fabricated by surfactant-free dispersion polymerization) will be presented: stealth biodegradable palctaxelloaded polylactide nanoparticles and stealth biodegradable docetaxel-loaded poly-Ã?µ-caprolactone nanoparticles.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 3 May 2019
Quality by design (QbD) approach towards the development and validation of a HPLC method for gentamicin content in biodegradable implants
Research article · 3 May 2019
Quality by Design (QbD) approach towards the development and validation of HPLC method for Gentamicin content in biodegradable implants
Conference abstract · 17 Nov 2015
Lipid and safety profile assessment of atorvastatin calcium loaded oral biodegradable polymeric nanoparticles in rats
Conference abstract
Quality-by-design approach for formulation development of drug nanoparticles
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Emmanuel O Akala”
